PER1
Period circadian protein homolog 1
Also known as: PER, PER1_HUMAN, RIGUI
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O15534
- Gene
- PER1
- Ensembl
- ENSG00000179094
- Chromosome
- 17
- Canonical length
- 1290 aa
- Protein class
- Cancer-related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene is a member of the Period family of genes and is expressed in a circadian pattern in the suprachiasmatic nucleus, the primary circadian pacemaker in the mammalian brain. Genes in this family encode components of the circadian rhythms of locomotor activity, metabolism, and behavior. This gene is upregulated by CLOCK/ARNTL heterodimers but then represses this upregulation in a feedback loop using PER/CRY heterodimers to interact with CLOCK/ARNTL. Polymorphisms in this gene may increase the risk of getting certain cancers. Alternative splicing has been observed in this gene; however, these variants have not been fully described. [provided by RefSeq, Jan 2014]
Canonical amino-acid sequenceUniProt
1290 residues, UniProt reviewed canonical sequence.
>O15534|PER1
1 MSGPLEGADG GGDPRPGESF CPGGVPSPGP PQHRPCPGPS LADDTDANSN GSSGNESNGH
61 ESRGASQRSS HSSSSGNGKD SALLETTESS KSTNSQSPSP PSSSIAYSLL SASSEQDNPS
121 TSGCSSEQSA RARTQKELMT ALRELKLRLP PERRGKGRSG TLATLQYALA CVKQVQANQE
181 YYQQWSLEEG EPCSMDMSTY TLEELEHITS EYTLQNQDTF SVAVSFLTGR IVYISEQAAV
241 LLRCKRDVFR GTRFSELLAP QDVGVFYGST APSRLPTWGT GASAGSGLRD FTQEKSVFCR
301 IRGGPDRDPG PRYQPFRLTP YVTKIRVSDG APAQPCCLLI AERIHSGYEA PRIPPDKRIF
361 TTRHTPSCLF QDVDERAAPL LGYLPQDLLG APVLLFLHPE DRPLMLAIHK KILQLAGQPF
421 DHSPIRFCAR NGEYVTMDTS WAGFVHPWSR KVAFVLGRHK VRTAPLNEDV FTPPAPSPAP
481 SLDTDIQELS EQIHRLLLQP VHSPSPTGLC GVGAVTSPGP LHSPGSSSDS NGGDAEGPGP
541 PAPVTFQQIC KDVHLVKHQG QQLFIESRAR PQSRPRLPAT GTFKAKALPC QSPDPELEAG
601 SAPVQAPLAL VPEEAERKEA SSCSYQQINC LDSILRYLES CNLPSTTKRK CASSSSYTTS
661 SASDDDRQRT GPVSVGTKKD PPSAALSGEG ATPRKEPVVG GTLSPLALAN KAESVVSVTS
721 QCSFSSTIVH VGDKKPPESD IIMMEDLPGL APGPAPSPAP SPTVAPDPAP DAYRPVGLTK
781 AVLSLHTQKE EQAFLSRFRD LGRLRGLDSS STAPSALGER GCHHGPAPPS RRHHCRSKAK
841 RSRHHQNPRA EAPCYVSHPS PVPPSTPWPT PPATTPFPAV VQPYPLPVFS PRGGPQPLPP
901 APTSVPPAAF PAPLVTPMVA LVLPNYLFPT PSSYPYGALQ TPAEGPPTPA SHSPSPSLPA
961 LAPSPPHRPD SPLFNSRCSS PLQLNLLQLE ELPRAEGAAV AGGPGSSAGP PPPSAEAAEP
1021 EARLAEVTES SNQDALSGSS DLLELLLQED SRSGTGSAAS GSLGSGLGSG SGSGSHEGGS
1081 TSASITRSSQ SSHTSKYFGS IDSSEAEAGA ARGGAEPGDQ VIKYVLQDPI WLLMANADQR
1141 VMMTYQVPSR DMTSVLKQDR ERLRAMQKQQ PRFSEDQRRE LGAVHSWVRK GQLPRALDVM
1201 ACVDCGSSTQ DPGHPDDPLF SELDGLGLEP MEEGGGEQGS SGGGSGEGEG CEEAQGGAKA
1261 SSSQDLAMEE EEEGRSSSSP ALPTAGNCTSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PER1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.58
- Highest tissue expression
- 201 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 201 nTPM
- skin: 171 nTPM
- blood vessel: 161 nTPM
- ovary: 158 nTPM
- adipose tissue: 122 nTPM
- breast: 109 nTPM
Single-cell type
- pituicytes/fscs: 294 nCPM
- neutrophils: 190 nCPM
- epididymal principal cells: 164 nCPM
- mast cells: 139 nCPM
- epicardial cells: 136 nCPM
- müller glia: 136 nCPM
Immune cell
- myeloid DC: 1.7 nTPM
- classical monocyte: 1.2 nTPM
- neutrophil: 1.2 nTPM
- intermediate monocyte: 0.9 nTPM
- MAIT T-cell: 0.7 nTPM
- eosinophil: 0.6 nTPM
Brain region
- choroid plexus: 67 nTPM
- white matter: 65 nTPM
- cerebellum: 64 nTPM
- cerebral cortex: 61 nTPM
- hypothalamus: 58 nTPM
- midbrain: 56 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.47
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.2
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- chromatin remodeling
- circadian regulation of gene expression
- circadian rhythm
- entrainment of circadian clock
- entrainment of circadian clock by photoperiod
- negative regulation of canonical NF-kappaB signal transduction
- negative regulation of DNA-templated transcription
- negative regulation of JNK cascade
- negative regulation of nuclear receptor-mediated glucocorticoid signaling pathway
- negative regulation of transcription by RNA polymerase II
- positive regulation of transcription by RNA polymerase II
- post-transcriptional regulation of gene expression
- regulation of circadian rhythm
- regulation of cytokine production involved in inflammatory response
- regulation of hair cycle
- regulation of p38MAPK cascade
- regulation of sodium ion transport
- response to cAMP
Molecular functions
- chromatin DNA binding
- DNA-binding transcription factor binding
- E-box binding
- kinase binding
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- transcription cis-regulatory region binding
- transcription corepressor binding
- ubiquitin protein ligase binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- PAS domain
- PAS fold 3
- Period circadian-like, C-terminal
- PAS domain superfamily
- Period circadian protein homolog 1-3, PAS-A domain
- Period circadian regulator
- Period circadian protein homolog PER 1-3, bHLH-like domain
- PAS fold
- Period circadian-like, C-terminal
- Period circadian protein homolog 3-like, PAS-A domain
- Period circadian protein homolog bHLH-like domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PER1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PER1 as an antibody target. Whether an autoantibody or antibody against PER1 could matter depends on whether native PER1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PER1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PER1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...